Epstein Barr Virus News and Research

Latest Epstein Barr Virus News and Research

Remdesivir resistance in renal transplant patients with long COVID-19

A new study has reported two renal transplant cases, in which individuals, after being exposed to remdesivir, developed a resistance to the drug.

1 Jul 2022

Epstein-Barr virus can reactivate in long COVID

In a recent study posted to the medRxiv* preprint server, researchers at the University of California, San Francisco, and Monogram Biosciences examined the connections between the post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC) and Epstein-Barr virus (EBV) reactivation.

23 Jun 2022

GPR183 gene a novel drug target for severe COVID-19

In a recent study posted to the bioRxiv* pre-print server, researchers provide the first preclinical evidence of the usefulness of antagonists of G-protein coupled receptor 183 (GPR183), also known as Epstein-Barr virus-induced gene 2 (EBI2), in reducing coronavirus disease 2019 (COVID-19) severity.

17 Jun 2022

The effectiveness of non-pharmacological treatments for post-viral syndromes and long COVID

A recent systematic review investigated the effectiveness of non-pharmacologic interventions for post-viral syndromes, including the post-COVID-19 syndrome.

9 Jun 2022

Study reports SARS-CoV-2 accessory proteins downregulate MHC-I expression using distinct mechanisms

Researchers observed SARS-CoV-2 downregulates the expression of MHC class I molecules.

23 May 2022

The enigma of post-acute infection syndromes

In a recent review published in the journal Nature Medicine, researchers summarized known literature findings of the unexplained post-acute infection syndromes (PAISs).

20 May 2022

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

In a new study, researchers evaluated the BNT162b2 coronavirus disease 2019 mRNA vaccine (antigen)-specific immune response among myeloid dysplastic syndrome and chronic lymphocytic leukemia patients.

18 May 2022

Exosomes derived from γδ-T cells synergized with radiotherapy can control nasopharyngeal carcinoma

A research team at LKS Faculty of Medicine, The University of Hong Kong discovered that exosomes derived from γδ-T cells (γδ-T-Exos) synergised with radiotherapy can control nasopharyngeal carcinoma (NPC) by overcoming the radioresistance of NPC cancer stem cells (CSCs) and preserve their tumor-killing and T cell-promoting activities in the immunosuppressive NPC microenvironment.

18 May 2022

UC Davis researchers identify a protein that keeps Kaposi's sarcoma-associated herpesvirus dormant

A team of UC Davis researchers has identified a protein in the cancer cell's nucleus as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's immune system.

11 May 2022

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial to evaluate an investigational preventative vaccine for Epstein-Barr virus (EBV).

6 May 2022

SARS-CoV-2 variants are not evolving to escape from T cell-mediated immunity

In a recent study posted to the bioRxiv* pre-print server, researchers demonstrated that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants did not evolve further to escape from T cell-mediated immunity.

6 May 2022

Acute hepatitis and adenovirus infection among pediatric patients in Alabama

A new study published by the Centers for Disease Control and Prevention (CDC) today, "Acute Hepatitis and Adenovirus Infection Among Children -; Alabama, October 2021–February 2022" provides additional clinical and epidemiologic information from an ongoing investigation involving children in Alabama with hepatitis (inflammation of the liver) of unknown cause.

5 May 2022

Epstein Barr Virus News and Research

Latest Epstein Barr Virus News and Research

Remdesivir resistance in renal transplant patients with long COVID-19

Epstein-Barr virus can reactivate in long COVID

GPR183 gene a novel drug target for severe COVID-19

The effectiveness of non-pharmacological treatments for post-viral syndromes and long COVID

Study reports SARS-CoV-2 accessory proteins downregulate MHC-I expression using distinct mechanisms

The enigma of post-acute infection syndromes

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

Exosomes derived from γδ-T cells synergized with radiotherapy can control nasopharyngeal carcinoma

UC Davis researchers identify a protein that keeps Kaposi's sarcoma-associated herpesvirus dormant

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

SARS-CoV-2 variants are not evolving to escape from T cell-mediated immunity

Acute hepatitis and adenovirus infection among pediatric patients in Alabama

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

Experimental tool can precisely pick out interactions between immune cell and target antigen

Air surveillance of SARS-CoV-2 and other respiratory pathogens

Japanese researchers discover new mechanisms of action by extracellular vesicles in lymphoma

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

Lung microbiome alterations and secondary-infections in lethal COVID-19

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Epstein Barr Virus News and Research

Latest Epstein Barr Virus News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in